{"success":true,"data":{"pressRelease":{"id":"104466","rtpr_id":"nGNX8CxYl2","ticker":"PRCT","exchange":"NASDAQ","all_tickers":["PRCT"],"title":"PROCEPT BioRobotics (PRCT) Faces Securities Class Action Amid Sales Pull-In Concerns – HBSS","author":"Globe Newswire","published_at":"2026-07-30T21:16:54.073Z","article_body":"SAN FRANCISCO, July 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics\nCorporation (NASDAQ: PRCT) faces a securities class action after repeated\nsurprise unit handpiece sales underperformance and gradual revelations of\nexcess customer inventory levels driven by repeated, late-quarter, bulk\ndiscounts. The lawsuit seeks to represent investors who purchased or otherwise\nacquired PROCEPT common stock between February 28, 2024 and February 25, 2026.\n\nNational shareholders rights firm Hagens Berman is investigating legal claims\nthat PROCEPT and the other Defendants violated the federal securities laws in\ntheir communications about sales of the company’s single-use handpiece, a\ncomponent of its proprietary Aquablation therapy used to treat patients with\nan enlarged prostate.\n\nThe firm encourages investors who suffered substantial losses to submit your\nlosses now\n(https://www.globenewswire.com/Tracker?data=mOHY0PwcwZFrXJnQ0viHGxiuUH76TAy9reqAoVos4XtqxRdllnRFNZn-jmrGMNK4SyDdB3eqDJEzf4e3WSC78mEzaTb97D-REo4XkHQ9433nZ_LKqAgWTzveICl34LuK).\nPersons with knowledge who may be able to assist the investigation are invited\nto contact the firm’s attorneys.\n\nClass Period: Feb. 28, 2024 – Feb. 25, 2026\nLead Plaintiff Deadline: Sept. 22, 2026\nVisit: www.hbsslaw.com/investor-fraud/prct \nContact the Firm Now: PRCT@hbsslaw.com | 844-916-0895\n\nPROCEPT BioRobotics (PRCT) Securities Class Action:\n\nThe lawsuit alleges that during the Class Period, the defendants withheld\ncrucial information from investors about PROCEPT’s business, operations, and\nfinancial condition. Its focus is on the propriety of the company’s\nstatements and omissions related to handpiece sales practices in the U.S.,\nincluding repeated touting of growth in those sales.\n\nMore specifically, the complaint alleges that (unknown to investors) the\nwrongdoing consisted of company’s utilization of an extensive discount\nprogram to incentivize its customers to place bulk orders exceeding\ncustomers’ procedures demands, pulling forward sales at the expense of\nfuture periods and, thereby, artificially inflating reported unit sales and\nrevenues.\n\nInvestors began to learn the truth through a series of partial disclosures,\neach of which drove the price of PROCEPT shares sharply lower.\n\nOn August 6, 2025, PROCEPT announced its Q2 2025 financial results, revealing\nthat the company’s handpiece sales unexpectedly deteriorated, missing\nconsensus estimates by a wide margin.\n\nThen, on November 4, 2025 PROCEPT reported its Q3 2025 results, again missing\nexpected handpiece unit sales. During the corresponding earnings call,\nmanagement slashed annual handpiece unit sales guidance to allow for the\n“optimization of field inventory[,]” and said PROCEPT had not “been\nmanaging customer inventory[,]” adding that some customers were “probably\ncarrying too much.”\n\nFinally, on February 25, 2026 PROCEPT announced Q4 2025 results. For the first\ntime, the company disclosed the actual number of procedures in the field and\nrevealed that U.S. handpiece sales materially exceeded procedures in each\nquarter since Q1 2023.\n\nOf concern was that cumulative excess customer inventory of handpieces were\nover 10,000 units and U.S. handpiece sales sequentially cratered by 30%.\nManagement then said that the company was eliminating its (previously\nundisclosed) bulk order discount program which was designed to incentivize\ncustomers to make large purchases during “the final weeks” of every\nquarter. The problem was the bulk order discount program essentially ate into\nfuture sales as customers already had excess inventories.\n\nAs a result of these events, by February 25, the price of PROCEPT shares had\nsteadily declined by $22.06, or over 48% from the close on August 6, 2025.\n\n“We’re focused on whether PROCEPT may have intentionally pulled-in sales\nfrom future quarters to make it seem like the company was meeting expectations\nand, if so, whether the company had been sufficiently transparent in its\ninvestor communications,” said Reed Kathrein\n(https://www.globenewswire.com/Tracker?data=WrGdcq-BhUeSLrZHqIh7SW5uxCgUNtlQKQwtMYmVQh_-pQA6zJssazelyOiPaKmHAeyo0f5ZVLWbjCwikPMbExuHO8MrCxmvpKocBzs6M9-lK9WnfqF9dkiUV5ON1Rvx),\nthe Hagens Berman partner leading the firm’s investigation.\n\nIf you invested in PROCEPT and have substantial losses, or have knowledge that\nwill assist the firm’s investigation, submit your losses now\n(https://www.globenewswire.com/Tracker?data=mOHY0PwcwZFrXJnQ0viHGxiuUH76TAy9reqAoVos4XscOSXuvLVcFygbIiteiRp9WJWJsRxI1crO9RNFOut-wvsDq3fv-zfAkuyl2bcLLCKOZZBYR7DMUyw0VT4jwyUY).\n\nIf you’d like more information and answers to other frequently asked\nquestions about the PROCEPT case and the firm’s investigation, read more\n(https://www.globenewswire.com/Tracker?data=UaXr4nVdF8l_44kPV488ttk3JEtS-KMvlC3ncBv7CsSqDly2TGefpnCMu_8pLSvyL-tAdpZV96Vl8_MThmIdWR4BzIryIjdXwT9skLgKT0CPU-zTTQ66B0-gs_LcIyUAYlebhd9SACSlMdR2wWUrZy04W5xTmcrnVtz5wapmCW0=).\n\nWhistleblowers: Persons with non-public information regarding PROCEPT should\nconsider their options to help in the investigation or take advantage of the\nSEC Whistleblower program. Under the new program, whistleblowers who provide\noriginal information may receive rewards totaling up to 30 percent of any\nsuccessful recovery made by the SEC. For more information, call Reed Kathrein\nat 844-916-0895 or email PRCT@hbsslaw.com.\n\nAbout Hagens Berman\n(https://www.globenewswire.com/Tracker?data=pVb3ykTjIvhDKtB1hzXZkKP2AS43O9k3WBXbnzz88BrcOhK3vycRx1SsfjuBKSutgg946eKMHy0U1N_TFLipnLSQjlsorDV8R-lKBQdntvw=)\nHagens Berman is a global plaintiffs’ rights complex litigation firm\nfocusing on corporate accountability. The firm is home to a robust practice\nand represents investors as well as whistleblowers, workers, consumers and\nothers in cases achieving real results for those harmed by corporate\nnegligence and other wrongdoings. Hagens Berman’s team has secured more than\n$2.9 billion in this area of law. More about the firm and its successes can be\nfound at hbsslaw.com\n(https://www.globenewswire.com/Tracker?data=SLd_CTHAuilN0OqqhtGiodZMx2EMPCgYi3ShPPAgx14wAuTWSwzbgF59ggoQJwZtqaju41-BFfK7jJVG8LSiJQ==).\nFollow the firm for updates and news at @ClassActionLaw. \n\nAttorney Advertising. Prior results do not guarantee a similar outcome in any\nfuture case.\n\nContact: \nReed Kathrein, 844-916-0895\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8CxYl2","title":"PROCEPT BioRobotics (PRCT) Faces Securities Class Action Amid Sales Pull-In Concerns – HBSS","author":"Globe Newswire","ticker":"PRCT","created":"2026-07-30T21:16:54.073Z","tickers":["PRCT"],"exchange":"NASDAQ","article_body":"SAN FRANCISCO, July 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics\nCorporation (NASDAQ: PRCT) faces a securities class action after repeated\nsurprise unit handpiece sales underperformance and gradual revelations of\nexcess customer inventory levels driven by repeated, late-quarter, bulk\ndiscounts. The lawsuit seeks to represent investors who purchased or otherwise\nacquired PROCEPT common stock between February 28, 2024 and February 25, 2026.\n\nNational shareholders rights firm Hagens Berman is investigating legal claims\nthat PROCEPT and the other Defendants violated the federal securities laws in\ntheir communications about sales of the company’s single-use handpiece, a\ncomponent of its proprietary Aquablation therapy used to treat patients with\nan enlarged prostate.\n\nThe firm encourages investors who suffered substantial losses to submit your\nlosses now\n(https://www.globenewswire.com/Tracker?data=mOHY0PwcwZFrXJnQ0viHGxiuUH76TAy9reqAoVos4XtqxRdllnRFNZn-jmrGMNK4SyDdB3eqDJEzf4e3WSC78mEzaTb97D-REo4XkHQ9433nZ_LKqAgWTzveICl34LuK).\nPersons with knowledge who may be able to assist the investigation are invited\nto contact the firm’s attorneys.\n\nClass Period: Feb. 28, 2024 – Feb. 25, 2026\nLead Plaintiff Deadline: Sept. 22, 2026\nVisit: www.hbsslaw.com/investor-fraud/prct \nContact the Firm Now: PRCT@hbsslaw.com | 844-916-0895\n\nPROCEPT BioRobotics (PRCT) Securities Class Action:\n\nThe lawsuit alleges that during the Class Period, the defendants withheld\ncrucial information from investors about PROCEPT’s business, operations, and\nfinancial condition. Its focus is on the propriety of the company’s\nstatements and omissions related to handpiece sales practices in the U.S.,\nincluding repeated touting of growth in those sales.\n\nMore specifically, the complaint alleges that (unknown to investors) the\nwrongdoing consisted of company’s utilization of an extensive discount\nprogram to incentivize its customers to place bulk orders exceeding\ncustomers’ procedures demands, pulling forward sales at the expense of\nfuture periods and, thereby, artificially inflating reported unit sales and\nrevenues.\n\nInvestors began to learn the truth through a series of partial disclosures,\neach of which drove the price of PROCEPT shares sharply lower.\n\nOn August 6, 2025, PROCEPT announced its Q2 2025 financial results, revealing\nthat the company’s handpiece sales unexpectedly deteriorated, missing\nconsensus estimates by a wide margin.\n\nThen, on November 4, 2025 PROCEPT reported its Q3 2025 results, again missing\nexpected handpiece unit sales. During the corresponding earnings call,\nmanagement slashed annual handpiece unit sales guidance to allow for the\n“optimization of field inventory[,]” and said PROCEPT had not “been\nmanaging customer inventory[,]” adding that some customers were “probably\ncarrying too much.”\n\nFinally, on February 25, 2026 PROCEPT announced Q4 2025 results. For the first\ntime, the company disclosed the actual number of procedures in the field and\nrevealed that U.S. handpiece sales materially exceeded procedures in each\nquarter since Q1 2023.\n\nOf concern was that cumulative excess customer inventory of handpieces were\nover 10,000 units and U.S. handpiece sales sequentially cratered by 30%.\nManagement then said that the company was eliminating its (previously\nundisclosed) bulk order discount program which was designed to incentivize\ncustomers to make large purchases during “the final weeks” of every\nquarter. The problem was the bulk order discount program essentially ate into\nfuture sales as customers already had excess inventories.\n\nAs a result of these events, by February 25, the price of PROCEPT shares had\nsteadily declined by $22.06, or over 48% from the close on August 6, 2025.\n\n“We’re focused on whether PROCEPT may have intentionally pulled-in sales\nfrom future quarters to make it seem like the company was meeting expectations\nand, if so, whether the company had been sufficiently transparent in its\ninvestor communications,” said Reed Kathrein\n(https://www.globenewswire.com/Tracker?data=WrGdcq-BhUeSLrZHqIh7SW5uxCgUNtlQKQwtMYmVQh_-pQA6zJssazelyOiPaKmHAeyo0f5ZVLWbjCwikPMbExuHO8MrCxmvpKocBzs6M9-lK9WnfqF9dkiUV5ON1Rvx),\nthe Hagens Berman partner leading the firm’s investigation.\n\nIf you invested in PROCEPT and have substantial losses, or have knowledge that\nwill assist the firm’s investigation, submit your losses now\n(https://www.globenewswire.com/Tracker?data=mOHY0PwcwZFrXJnQ0viHGxiuUH76TAy9reqAoVos4XscOSXuvLVcFygbIiteiRp9WJWJsRxI1crO9RNFOut-wvsDq3fv-zfAkuyl2bcLLCKOZZBYR7DMUyw0VT4jwyUY).\n\nIf you’d like more information and answers to other frequently asked\nquestions about the PROCEPT case and the firm’s investigation, read more\n(https://www.globenewswire.com/Tracker?data=UaXr4nVdF8l_44kPV488ttk3JEtS-KMvlC3ncBv7CsSqDly2TGefpnCMu_8pLSvyL-tAdpZV96Vl8_MThmIdWR4BzIryIjdXwT9skLgKT0CPU-zTTQ66B0-gs_LcIyUAYlebhd9SACSlMdR2wWUrZy04W5xTmcrnVtz5wapmCW0=).\n\nWhistleblowers: Persons with non-public information regarding PROCEPT should\nconsider their options to help in the investigation or take advantage of the\nSEC Whistleblower program. Under the new program, whistleblowers who provide\noriginal information may receive rewards totaling up to 30 percent of any\nsuccessful recovery made by the SEC. For more information, call Reed Kathrein\nat 844-916-0895 or email PRCT@hbsslaw.com.\n\nAbout Hagens Berman\n(https://www.globenewswire.com/Tracker?data=pVb3ykTjIvhDKtB1hzXZkKP2AS43O9k3WBXbnzz88BrcOhK3vycRx1SsfjuBKSutgg946eKMHy0U1N_TFLipnLSQjlsorDV8R-lKBQdntvw=)\nHagens Berman is a global plaintiffs’ rights complex litigation firm\nfocusing on corporate accountability. The firm is home to a robust practice\nand represents investors as well as whistleblowers, workers, consumers and\nothers in cases achieving real results for those harmed by corporate\nnegligence and other wrongdoings. Hagens Berman’s team has secured more than\n$2.9 billion in this area of law. More about the firm and its successes can be\nfound at hbsslaw.com\n(https://www.globenewswire.com/Tracker?data=SLd_CTHAuilN0OqqhtGiodZMx2EMPCgYi3ShPPAgx14wAuTWSwzbgF59ggoQJwZtqaju41-BFfK7jJVG8LSiJQ==).\nFollow the firm for updates and news at @ClassActionLaw. \n\nAttorney Advertising. Prior results do not guarantee a similar outcome in any\nfuture case.\n\nContact: \nReed Kathrein, 844-916-0895\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-07-30T21:16:54.112855415Z","server_sent_at_ms":1785446214112},"received_at":"2026-07-30T21:16:54.162Z","source_url":null},"analysis":{"id":"93482","press_release_id":"104466","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Hagens Berman announced a securities class action investigation into PROCEPT BioRobotics regarding alleged undisclosed inventory levels and sales pull-in practices.\n\nThe complaint alleges the company used discount programs to drive bulk orders, resulting in over 10,000 units of excess inventory and a subsequent 48% share price decline.\n\nThe firm is soliciting investors who purchased stock between February 28, 2024, and February 25, 2026, to serve as lead plaintiff.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{"customDimensions":{"class_period_end":"February 25, 2026","class_period_start":"February 28, 2024","excess_inventory_units":"over 10,000","lead_plaintiff_deadline":"September 22, 2026","share_price_decline_amount":"$22.06","us_handpiece_sales_decline":"30%","share_price_decline_percent":"over 48%"}},"quotedText":"We’re focused on whether PROCEPT may have intentionally pulled-in sales from future quarters to make it seem like the company was meeting expectations and, if so, whether the company had been sufficiently transparent in its investor communications","namedEntities":{"people":[{"name":"Reed Kathrein","role":"Partner, Hagens Berman"}],"products":["Aquablation therapy","single-use handpiece"],"companies":[{"name":"PROCEPT BioRobotics Corporation","ticker":"PRCT"},{"name":"Hagens Berman","relationship":"plaintiff law firm"}],"dollarAmounts":[{"amount":"$22.06","context":"share price decline by February 25, 2026"},{"amount":"$2.9 billion","context":"past recoveries secured by Hagens Berman"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Hagens Berman. No new disclosure from the issuer; no certified class or settlement announced. Routine investigation announcement."},"tickerRelevance":{"others":[],"primary":"PRCT"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Hagens Berman announced a securities class action investigation into PROCEPT BioRobotics regarding alleged undisclosed inventory levels and sales pull-in practices.\n\nThe complaint alleges the company used discount programs to drive bulk orders, resulting in over 10,000 units of excess inventory and a subsequent 48% share price decline.\n\nThe firm is soliciting investors who purchased stock between February 28, 2024, and February 25, 2026, to serve as lead plaintiff.","key_figures":{"customDimensions":{"class_period_end":"February 25, 2026","class_period_start":"February 28, 2024","excess_inventory_units":"over 10,000","lead_plaintiff_deadline":"September 22, 2026","share_price_decline_amount":"$22.06","us_handpiece_sales_decline":"30%","share_price_decline_percent":"over 48%"}},"named_entities":{"people":[{"name":"Reed Kathrein","role":"Partner, Hagens Berman"}],"products":["Aquablation therapy","single-use handpiece"],"companies":[{"name":"PROCEPT BioRobotics Corporation","ticker":"PRCT"},{"name":"Hagens Berman","relationship":"plaintiff law firm"}],"dollarAmounts":[{"amount":"$22.06","context":"share price decline by February 25, 2026"},{"amount":"$2.9 billion","context":"past recoveries secured by Hagens Berman"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-31T02:49:14.936Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":280157,"modelName":"glm-4.7"}}